Recurrent Neuroblastoma Completed Phase 1 Trials for Tretinoin (DB00755)

Also known as: Neuroblastoma Recurrent

IndicationStatusPhase
DBCOND0028756 (Recurrent Neuroblastoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs